Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
Bhuvanesh Dave(University Hospital Galway), Jenny C. Chang(Universität Hamburg)
Cited by 259
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies
|American Journal of Clinical Nutrition|1999|488
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial
|Annals of Oncology|2021|371
Microenvironmental Regulation of Epithelial–Mesenchymal Transitions in Cancer
|Cancer Research|2012|302